tykhr
sign in
free sign up
Gracell Biotechnologies Inc.
Biotechnology
Healthcare
GRCL
67.71 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
9.97
52 week high
10.10
high
10.10
52 week low
1.45
low
9.97
growth
352.91 %
previous Close
10.04
P/E ratio
market cap
223 M
div yield
0
usd
Jun 2023
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
14.29 %
eps surprise
25.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top